-
Quadplex dPCR as a tool to analyze genome integrity and heterogeneity in gene therapy drug products
Quadplex dPCR as a tool to analyze genome integrity and heterogeneity in gene therapy drug products
Join QIAGEN for a BioInsights-hosted webinar on June 11 to hear from Ryan Massopust, a Scientist at Asklepios BioPharmaceutical, Inc. (AskBio), about his use of quadruplex digital PCR (dPCR) to evaluate genome integrity and heterogeneity in target-based AAV genome variants. As the gene therapy field rapidly grows, the need for product-specific analytics becomes crucial. Traditional [....]